Author

Yiqi Zhang

Observed names: Y Zhang, Zhang, Yiqi

Institution: Jinzhou Medical University

Observed institutions: Beth Israel Deaconess Medical Center, Harvard University, University of Massachusetts Amherst, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, First Affiliated Hospital of Liaoning Medical University, The Ohio State University, Jinzhou Medical University

ORCID: 0009-0009-3225-413X

Observed ORCID: 0009-0009-3225-413X

OpenAlex ID: A5043926512

SNORA5A regulates tumor-associated macrophage M1/M2 phenotypes via TRAF3IP3 in breast cancer

2024 · Yiqi Zhang, Ang Zheng, et al. · Brazilian Journal of Medical and Biological Research · 4

Establishment of a tumor-associated fibroblast associated gene score based on scRNA-seq to predict prognosis in patients with triple-negative breast cancer

2024 · Hao Yu, Ziqi Peng, et al. · PLoS ONE · 2

Abstract P1-09-01: CD8+ T-cell gene expression and signatures in breast cancer and adjacent normal breast tissue: Association with body mass index, alcohol intake, and age at diagnosis

2019 · A Damicis, YJ Heng, et al. · Cancer Research · 1

BAP18, as a corepressor of AR together with the SIN3A/HDAC complex, promotes AR-positive triple-negative breast cancer progression

2025 · Yiqi Zhang, Zining Jin, et al. · Cell & Bioscience

Abstract P3-07-08: Multi-omic predictor of rapid and late relapse in primary triple negative breast cancer

2019 · Y Zhang, W Nock, et al. · Cancer Research

Works count: 7

Citation count: 7

H-index: 2

I10-index: